Pfizer, Inc. Revenue 2007–2025
Pfizer, Inc. reported $62.58B of revenue for fiscal 2025. That was 1.6% lower than fiscal 2024. Compared with fiscal 2020, the change was +50.2%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $62.58B | -1.6% |
| FY 2024 | $63.63B | +6.8% |
| FY 2023 | $59.55B | -41.1% |
| FY 2022 | $101.17B | +24.5% |
| FY 2021 | $81.29B | +95.2% |
| FY 2020 | $41.65B | +1.8% |
| FY 2019 | $40.91B | +0.2% |
| FY 2018 | $40.83B | -22.3% |
| FY 2017 | $52.55B | -0.5% |
| FY 2016 | $52.82B | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | -100.0% |
| FY 2013 | $51.58B | -5.6% |
| FY 2012 | $54.66B | -10.4% |
| FY 2011 | $61.03B | -6.3% |
| FY 2010 | $65.17B | +32.3% |
| FY 2009 | $49.27B | +2.0% |
| FY 2008 | $48.30B | -0.3% |
| FY 2007 | $48.42B | — |
Source: Pfizer, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PFE 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Pfizer, Inc. reported $62.58B of revenue for fiscal 2025. That was 1.6% lower than fiscal 2024. Compared with fiscal 2020, the change was +50.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Pfizer, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePfizer, Inc. — frequently asked questions
What is Pfizer, Inc.'s revenue?
Pfizer, Inc. (PFE) reported revenue of $62.58B for fiscal year 2025, per its SEC filings.
How has Pfizer, Inc.'s revenue changed over time?
Between fiscal 2007 and 2025, PFE's revenue grew at roughly 1.4% per year (compound annual rate), from $48.42B to $62.58B.
Where does this data come from?
Figures are computed from Pfizer, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.